AU StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Argent BioPharma Limited

0.038

-0.001-2.56%

Volume:257.88K

Turnover:10K

Market Cap:4.43M

PE:-0.31

High:0.040

Open:0.038

Low:0.037

Close:0.039

52wk High:0.150

52wk Low:0.033

Shares:116.61M

Float Shares:27.70M

Volume Ratio:0.85

T/O Rate:0.93%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.123

EPS(LYR):-0.312

ROE:--

ROA:-243.04%

PB:-0.52

PE(LYR):-0.12

Loading ...

Overview Company News Filings

Argent Biopharma Ltd-US Veterinary Development Programme for Cannepil Commences

THOMSON REUTERS

Australia's Argent Biopharma Surges on Expanding CannEpil License to Veterinary Care

Argent Biopharma Ltd-Cannepil Global Licence Expands into Veterinary Healthcare

THOMSON REUTERS

ASX Runners of the Week: Argent, Peregrine, Newpeak Minerals & Caspin

The West Australian

Australia's Argent Biopharma Rises on $5.5 Million Global Licensing Deal

Argent Biopharma Ltd - to Receive a 15% Net Revenue Royalty on Future Sbev Global Cannepil Revenues

THOMSON REUTERS

Argent Biopharma - Enters a Global Licensing Transaction for Cannepil with Splash Beverage Group Inc

THOMSON REUTERS

Argent Biopharma - Transaction Includes $5.5 Mln Upfront Consideration for Global Licensing Rights

THOMSON REUTERS

Splash Beverage Group - Argent Biopharma to Receive 15% Royalty on Worldwide Cannepil Sales

THOMSON REUTERS

Splash Beverage Group Acquires Exclusive Global Rights to Cannepil®, an Epilepsy Therapy with Established European Patient Access, FDA Engagement and U.S. Development Potential

THOMSON REUTERS

Splash Beverage Group - Buys Exclusive Worldwide Rights to Develop and Sell Cannepil

THOMSON REUTERS

Splash Beverage Group - Issues $5.5 Mln Preferred Equity; $5 Mln Argent Biopharma Debt Forgiven as License Consideration

THOMSON REUTERS

Splash Beverage Group - Secures $1 Mln Strategic Investment from C/M Capital Partners for Cannepil Development

THOMSON REUTERS

BRIEF-Argent Biopharma Enters Long Term Aquiol Licensing And Supply Agreement

Argent Biopharma Ltd - Agreement Grants Exclusive Worldwide Use of Aquiol for Dermatology Cosmetic Applications

THOMSON REUTERS

Argent Biopharma Ltd-Long Term Aquiol Licensing and Supply Agreement

THOMSON REUTERS

Argent Biopharma Ltd - Enters Long-Term Licensing and Supply Agreement With the Skin Health Institute

THOMSON REUTERS

Argent Biopharma Ltd - Agreement Includes €3,000 Monthly Royalty Plus 5% Revenue-Linked Royalty

THOMSON REUTERS

Argent Biopharma Ltd-Appointment of Executive Director

THOMSON REUTERS

Argent BioPharma H1 revenue jumps 39.0x to AUD 171,499

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.gotigerhk.com/stock/RGT.AU/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"RGT.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"RGT.AU\",,,,,undefined,":{"symbol":"RGT.AU","market":"AU","secType":"STK","nameCN":"Argent BioPharma Limited","latestPrice":0.038,"timestamp":1787292720000,"preClose":0.039,"halted":0,"volume":257884,"delay":0,"changeRate":-0.025641025641025664,"nameEN":"Argent BioPharma Limited","floatShares":27704074,"shares":116609584,"eps":-0.123189,"marketStatus":"Market Closed","change":-0.001,"latestTime":"08-21 16:12:00 AEST","open":0.038,"high":0.04,"low":0.037,"amount":9883,"amplitude":0.076923,"askPrice":0.039,"askSize":273347,"bidPrice":0.038,"bidSize":1214,"shortable":3,"etf":0,"ttmEps":-0.123189,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1787529600000},"marketStatusCode":7,"adr":0,"exchange":"ASX","adjPreClose":0.039,"openAndCloseTimeList":[[1787270400000,1787292000000]],"volumeRatio":0.8513433840412936,"lotSize":1,"tradeCurrency":"AUD","auctionPricing":{"symbol":"RGT.AU","preClose":0.039,"auctionPrice":0.038,"auctionVolume":150,"auction":3,"marketStatus":"盘后竞价","timestamp":1787292005722}},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"RGT.AU\",,,,,undefined,":{"symbol":"RGT.AU","floatShares":27704074,"roa":"-243.04%","roe":"--","lyrEps":-0.312116,"volumeRatio":0.8513433840412936,"shares":116609584,"dividePrice":0,"high":0.04,"amplitude":0.076923,"preClose":0.039,"low":0.037,"week52Low":0.033,"pbRate":"-0.52","psRate":"12.74","week52High":0.15,"institutionHeld":0,"latestPrice":0.038,"committee":-0.991157,"eps":-0.123189,"divideRate":0,"volume":257884,"delay":0,"ttmEps":-0.123189,"open":0.038,"prevYearClose":0.07,"prevWeekClose":0.04,"prevMonthClose":0.04,"prevQuarterClose":0.036,"fiveDayClose":0.04,"twentyDayClose":0.05,"sixtyDayClose":0.038},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/RGT.AU\",params:#limit:5,,,undefined,":[{"market":"AU","date":"2024-09-23","symbol":"RGT.AU","reason":null,"defaultRemindTime":1727049600000,"announcedDate":"2024-08-15","type":"delisting","dateTimestamp":1727013600000}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"RGT.AU\",market:\"AU\",,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"RGT.AU\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2657557269","title":"Argent Biopharma Ltd-US Veterinary Development Programme for Cannepil Commences","url":"https://stock-news.laohu8.com/highlight/detail?id=2657557269","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657557269?lang=en_us&edition=fundamental","pubTime":"2026-08-06 07:14","pubTimestamp":1785971685,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260805:nTUE9MXBBC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7096","RGT.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655339965","title":"Australia's Argent Biopharma Surges on Expanding CannEpil License to Veterinary Care","url":"https://stock-news.laohu8.com/highlight/detail?id=2655339965","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655339965?lang=en_us&edition=fundamental","pubTime":"2026-07-31 12:18","pubTimestamp":1785471491,"startTime":"0","endTime":"0","summary":"BUZZ-Australia's Argent Biopharma surges on expanding CannEpil license to veterinary care** Shares of Australia's Argent BiopharmaRGT.AXrise as much as 75.7% to A$0.065, their highest since July 23** ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260731:nL4N43X0EB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7096","RGT.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655438266","title":"Argent Biopharma Ltd-Cannepil Global Licence Expands into Veterinary Healthcare","url":"https://stock-news.laohu8.com/highlight/detail?id=2655438266","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655438266?lang=en_us&edition=fundamental","pubTime":"2026-07-31 07:23","pubTimestamp":1785453820,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260730:nTUEBTFCJP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7096","RGT.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650985904","title":"ASX Runners of the Week: Argent, Peregrine, Newpeak Minerals & Caspin","url":"https://stock-news.laohu8.com/highlight/detail?id=2650985904","media":"The West Australian","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650985904?lang=en_us&edition=fundamental","pubTime":"2026-07-10 05:29","pubTimestamp":1783632596,"startTime":"0","endTime":"0","summary":"The Bulls N’ Bears ASX Runner of the Week is… Argent BioPharma, striking a smart licensing deal for its CannEpil epilepsy drug that wipes out a major debt overhang while retaining blue-sky through royalties.","market":"hk","thumbnail":"https://images.thewest.com.au/publication/C-22560047/f3ba145e5bde0aa97d4b38a2ae55d7e52f82c4d9.jpg","type":0,"news_type":0,"thumbnails":["https://images.thewest.com.au/publication/C-22560047/f3ba145e5bde0aa97d4b38a2ae55d7e52f82c4d9.jpg"],"rights":{"source":"thewest_stock","url":"https://thewest.com.au/business/bulls-n-bears/asx-runners-of-the-week-argent-peregrine-newpeak-minerals-caspin--c-22560047","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://thewest.com.au/business/bulls-n-bears/asx-runners-of-the-week-argent-peregrine-newpeak-minerals-caspin--c-22560047","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"thewest_stock","symbols":["FGDL","GDXJ","PGD.AU","KGLD","DULL","GLDM","GLTR","GOLY","BTGD","PHYS","CEF","GDXD","MTX","RGT.AU","SHNY","DGP","BEGS","UGL","DBC","XME","DZZ","PPI","NPM.AU","GBUG","SGDM","GLD","CPN.AU","GLDY","IAUM","GDXY","UYM","GDX","BGLD","JDST","GLL","IAUI","USG","YGLD","AAAU","RING","PICK","SGOL","GDXU","BAR","IGLD","JNUG","GOAU","IAU","DUST","OUNZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649660540","title":"Australia's Argent Biopharma Rises on $5.5 Million Global Licensing Deal","url":"https://stock-news.laohu8.com/highlight/detail?id=2649660540","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649660540?lang=en_us&edition=fundamental","pubTime":"2026-07-07 11:41","pubTimestamp":1783395708,"startTime":"0","endTime":"0","summary":"BUZZ-Australia's Argent BioPharma rises on $5.5 million global licensing deal** Shares of Argent BioPharmaRGT.AXrise 148.6% to A$0.087, their highest level since November 10** Companyexecutesglobal li","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260707:nL4N43908U:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7096","RGT.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649724706","title":"Argent Biopharma Ltd - to Receive a 15% Net Revenue Royalty on Future Sbev Global Cannepil Revenues","url":"https://stock-news.laohu8.com/highlight/detail?id=2649724706","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649724706?lang=en_us&edition=fundamental","pubTime":"2026-07-07 07:24","pubTimestamp":1783380249,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260706:nFWN4380XO:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["RGT.AU","SBEV","BK4113","BK7096","BK4169"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649672477","title":"Argent Biopharma - Enters a Global Licensing Transaction for Cannepil with Splash Beverage Group Inc","url":"https://stock-news.laohu8.com/highlight/detail?id=2649672477","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649672477?lang=en_us&edition=fundamental","pubTime":"2026-07-07 07:24","pubTimestamp":1783380249,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260706:nFWN4380XO:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["RGT.AU","BK4113","BK4169","SBEV","BK7096"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649672403","title":"Argent Biopharma - Transaction Includes $5.5 Mln Upfront Consideration for Global Licensing Rights","url":"https://stock-news.laohu8.com/highlight/detail?id=2649672403","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649672403?lang=en_us&edition=fundamental","pubTime":"2026-07-07 07:24","pubTimestamp":1783380249,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260706:nFWN4380XO:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4169","BK7096","RGT.AU","BK4113","SBEV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649921621","title":"Splash Beverage Group - Argent Biopharma to Receive 15% Royalty on Worldwide Cannepil Sales","url":"https://stock-news.laohu8.com/highlight/detail?id=2649921621","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649921621?lang=en_us&edition=fundamental","pubTime":"2026-07-06 20:30","pubTimestamp":1783341000,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260706:nTUA85VBKN:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["RGT.AU","SBEV","BK4169","BK4113","BK7096"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649912621","title":"Splash Beverage Group Acquires Exclusive Global Rights to Cannepil®, an Epilepsy Therapy with Established European Patient Access, FDA Engagement and U.S. Development Potential","url":"https://stock-news.laohu8.com/highlight/detail?id=2649912621","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649912621?lang=en_us&edition=fundamental","pubTime":"2026-07-06 20:30","pubTimestamp":1783341000,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260706:nTUA85VBKN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7096","RGT.AU","BK4113","BK4169","SBEV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649762191","title":"Splash Beverage Group - Buys Exclusive Worldwide Rights to Develop and Sell Cannepil","url":"https://stock-news.laohu8.com/highlight/detail?id=2649762191","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649762191?lang=en_us&edition=fundamental","pubTime":"2026-07-06 20:30","pubTimestamp":1783341000,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260706:nTUA85VBKN:5","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7096","BK4169","RGT.AU","BK4113","SBEV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649662199","title":"Splash Beverage Group - Issues $5.5 Mln Preferred Equity; $5 Mln Argent Biopharma Debt Forgiven as License Consideration","url":"https://stock-news.laohu8.com/highlight/detail?id=2649662199","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649662199?lang=en_us&edition=fundamental","pubTime":"2026-07-06 20:30","pubTimestamp":1783341000,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260706:nTUA85VBKN:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4113","BK4169","RGT.AU","SBEV","BK7096"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649621993","title":"Splash Beverage Group - Secures $1 Mln Strategic Investment from C/M Capital Partners for Cannepil Development","url":"https://stock-news.laohu8.com/highlight/detail?id=2649621993","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649621993?lang=en_us&edition=fundamental","pubTime":"2026-07-06 20:30","pubTimestamp":1783341000,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260706:nTUA85VBKN:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7096","SBEV","BK4169","RGT.AU","BK4113"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638677589","title":"BRIEF-Argent Biopharma Enters Long Term Aquiol Licensing And Supply Agreement","url":"https://stock-news.laohu8.com/highlight/detail?id=2638677589","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638677589?lang=en_us&edition=fundamental","pubTime":"2026-05-25 09:50","pubTimestamp":1779673829,"startTime":"0","endTime":"0","summary":"BRIEF-Argent Biopharma Enters Long Term Aquiol Licensing And Supply AgreementMay 25 (Reuters) - Argent BioPharma Ltd RGT.AX:LONG TERM AQUIOL LICENSING AND SUPPLY AGREEMENTENTERS LONG-TERM LICENSING AN","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260525:nTUEBSY3XK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RGT.AU","BK7096"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638588246","title":"Argent Biopharma Ltd - Agreement Grants Exclusive Worldwide Use of Aquiol for Dermatology Cosmetic Applications","url":"https://stock-news.laohu8.com/highlight/detail?id=2638588246","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638588246?lang=en_us&edition=fundamental","pubTime":"2026-05-25 07:06","pubTimestamp":1779664009,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260524:nTUEBSY3XK:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7096","RGT.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638588244","title":"Argent Biopharma Ltd-Long Term Aquiol Licensing and Supply Agreement","url":"https://stock-news.laohu8.com/highlight/detail?id=2638588244","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638588244?lang=en_us&edition=fundamental","pubTime":"2026-05-25 07:06","pubTimestamp":1779664009,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260524:nTUEBSY3XK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["RGT.AU","BK7096"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638588240","title":"Argent Biopharma Ltd - Enters Long-Term Licensing and Supply Agreement With the Skin Health Institute","url":"https://stock-news.laohu8.com/highlight/detail?id=2638588240","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638588240?lang=en_us&edition=fundamental","pubTime":"2026-05-25 07:06","pubTimestamp":1779664009,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260524:nTUEBSY3XK:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["RGT.AU","BK7096"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638249588","title":"Argent Biopharma Ltd - Agreement Includes €3,000 Monthly Royalty Plus 5% Revenue-Linked Royalty","url":"https://stock-news.laohu8.com/highlight/detail?id=2638249588","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638249588?lang=en_us&edition=fundamental","pubTime":"2026-05-25 07:06","pubTimestamp":1779664009,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260524:nTUEBSY3XK:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7096","RGT.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633497351","title":"Argent Biopharma Ltd-Appointment of Executive Director","url":"https://stock-news.laohu8.com/highlight/detail?id=2633497351","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633497351?lang=en_us&edition=fundamental","pubTime":"2026-05-06 07:01","pubTimestamp":1778022094,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260505:nTUEJYWKR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["RGT.AU","BK7096"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614884316","title":"Argent BioPharma H1 revenue jumps 39.0x to AUD 171,499","url":"https://stock-news.laohu8.com/highlight/detail?id=2614884316","media":"Reuters","labels":["dataReport","event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614884316?lang=en_us&edition=fundamental","pubTime":"2026-02-27 15:20","pubTimestamp":1772176848,"startTime":"0","endTime":"0","summary":"Argent BioPharma reported revenue from ordinary activities of AUD 171,499 for H1 ended 31 December 2025, a 39.0x increase, and a net loss attributable to members of AUD 2.9 million . Net tangible assets per share were (0.1) cents at 31 December 2025. Cash and cash equivalents were AUD 1.5 million at 31 December 2025, while net cash used in operating activities was AUD 2.6 million for H1. During the period, Argent BioPharma began formal supply of EU-GMP cannabinoid API to University Medical Centre Ljubljana for drug-resistant epilepsy, and published a peer-reviewed CannEpil case study in treatment-resistant epilepsy. The company also cited an independent in vivo study by the University of South Florida showing up to 85% survival in treated mice for ArtemiC in a viral inflammatory model. In December 2025, the group liquidated its Slovenian subsidiary following a decision to cease operations at its Slovenia manufacturing facility, recording a AUD 55,395 loss on liquidation. Subsequent to ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260227:nNDL9BBpN2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":"Argent BioPharma H1 revenue jumps 39.0x to AUD 171,499","news_tag":"dataReport,event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7096","RGT.AU"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":1,"totalSize":22,"code":"91000000","status":"200"}]}}